Catamenial epilepsy: hormonal aspects

References

• Tempkin O. The falling sickness: a history of epilepsy from the Greeks to the beginnings of modern neurology. Baltimore: The Johns Hopkins Press; 1945.
   Google Scholar
• Locock C. Discussion. Analysis of fifty-two cases of epilepsy observed by the author. Med Times Gaz 1857;14:524–526.
   Google Scholar
• Gowers WR. Epilepsy and other chronic convulsive diseases. Their causes, symptoms, and treatment. London: J&A Churchill;1881.
   Google Scholar
• Duncan S, Read CL, Brodie MJ. How common is catamenial epilepsy? Epilepsia 1993;34:827–831.
   PubMed Web of Science ®Google Scholar
• Herzog AG, Klein P, Ransil BJ. Three patterns of catamenial epilepsy. Epilepsia 1997;38:1082–1088.
   PubMed Web of Science ®Google Scholar
• Tuveri A, Paoletti AM, Orru M, Melis GB, Marotto MF, Zedda P, Marrosu F, Sogliano C, Marra C, Biggio G, et al Reduced serum level of THDOC, an anticonvulsant steroid, in women with perimenstrual catamenial epilepsy. Epilepsia 2008;49:1221–1229.
   PubMed Web of Science ®Google Scholar
• Reddy DS. Perimenstrual catamenial epilepsy. Women's Health 2007;3:95–206.
   Google Scholar
• Taubøll E, Lundervold A, Gjerstad L. Temporal distribution of seizures in epilepsy. Epilepsy Res 1991;8:153–165.
   PubMed Web of Science ®Google Scholar
• Herzog AG, Harden CL, Liporace J, Pennell P, Schomer DL, Sperling M, Fowler K, Nikolov B, Shuman S, Newman M. Frequency of catamenial seizure exacerbation in women with localization-related epilepsy. Ann Neurol 2004;56:431–434.
   PubMed Web of Science ®Google Scholar
• Bazan AC, Montenegro MA, Cendes F, Min LL, Guerreiro CA. Menstrual cycle worsening of epileptic seizures in women with symptomatic focal epilepsy. Arq Neuropsiquiatr 2005;63:751–756.
   PubMed Web of Science ®Google Scholar
• Marques-Assis L. Influence of menstruation on epilepsy. Arq Neuropsiquiatr 1981;39:390–395.
   PubMedGoogle Scholar
• Morrell MJ. Epilepsy in women: the science of why it is special. Neurology 1999;53:S42–S48.
   Web of Science ®Google Scholar
• Foldvary-Schaefer N, Falcone T. Catamenial epilepsy: pathophysiology, diagnosis, and management. Neurology 2003;61:S2–S15.
   Web of Science ®Google Scholar
• Reddy DS, Rogawski MA. Neurosteroid replacement therapy for catamenial epilepsy. Neurotherapeutics 2009;6:392–401.
   PubMed Web of Science ®Google Scholar
• Pennell PB. Antiepileptic drugs during pregnancy: what is known and which AEDs seem to be safest? Epilepsia 2008;49:S43–S55.
   PubMed Web of Science ®Google Scholar
• Smith SS. Estrogen administration increases neuronal responses to excitatory amino acids as a long term effect. Brain Res 1989;503:354–357.
   PubMed Web of Science ®Google Scholar
• Wong M, Moss R. Long-term and short-term electrophysiological effects of estrogen on the synaptic properties of hippocampal CA1 neurons. J Neurosci 1992;12:3217–3225.
   PubMed Web of Science ®Google Scholar
• Kawakami M, Teresawa E, Ibuki T. Changes in multiple unit activity in the brain during the estrous cycle. Neuroendocrinol 1970;6:30–48.
   PubMed Web of Science ®Google Scholar
• Woolley CS, McEwen BS. Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J Comp Neurol 1993;336:293–306.
   PubMed Web of Science ®Google Scholar
• Woolley CS, McEwen BS. Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor- dependent mechanism. J Neurosci 1994;14:7680–7687.
   PubMed Web of Science ®Google Scholar
• Pfaff DW, Keiner M. Estradiol-concentrating cells in the rat amygdala as part of a limbic-hypothalamic hormone-sensitive system. In: Eleftheriou B, editor. The neurobiology of the amygdala. New York: Plenum Publishing; 1973. pp 775–792.
   Google Scholar
• Simerly RB, Chang C, Muramatsu M, Swanson LW. Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study. J Comp Neurol 1990;294:76–95.
   PubMed Web of Science ®Google Scholar
• McEwen BS. Nongenomic and genomic effects of steroids on neural activity. Trends Pharmacol Sci 1991;12:141–147.
   PubMed Web of Science ®Google Scholar
• Finn DA, Gee KW. The influence of estrus cycle phase on neurosteroid potency at the GABA-A receptor complex. J Pharmacol Exp Ther 1993;265:1374–1379.
   PubMed Web of Science ®Google Scholar
• Wallis CJ, Luttge WG. Influence of estrogen and progesterone on glutamic acid decarboxylase activity in discrete regions of rat brain. J Neurochem 1980;34:609–613.
   PubMed Web of Science ®Google Scholar
• Luine VN, Renner KJ, McEwen BS. Sex-dependent differences in estrogen regulation of choline acetyltransferase are altered by neonatal treatments. Endocrinology 1986;119:874–878.
   PubMed Web of Science ®Google Scholar
• Logothetis J, Harner R, Morrel F. The role of estrogens in catamenial exacerbation of epilepsy. Neurology 1959;9:352–360.
   PubMed Web of Science ®Google Scholar
• Backstrom T. Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle. Acta Neurol Scand 1976;54:321–347.
   PubMed Web of Science ®Google Scholar
• Jacono JJ, Robinson J. The effects of estrogen, progesterone, and ionized calcium on seizures during the menstrual cycle in epileptic women. Epilepsia 1987;28:571–577.
   PubMed Web of Science ®Google Scholar
• Lin TY, Greenblatt M, Soloman HC. A polygraphic study of one case of petit mal epilepsy: effects of medication and menstruation. Electroencephalogr Clin Neurophysiol 1952;4:351–355.
   PubMedGoogle Scholar
• El-Khayat HA, Soliman NA, Tomoum HY, Omran MA, El- Wakad AS, Shatla RH. Reproductive hormonal changes and catamenial pattern in adolescent females with epilepsy. Epilepsia 2008;49:1619–1626.
   PubMed Web of Science ®Google Scholar
• Paul SM, Purdy RH. Neuroactive steroids. FASEB J 1992;6:2311–2322.
   PubMed Web of Science ®Google Scholar
• Majewska MD, Harrison NL, Schwartz RD, Barker JL, Paul SM. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 1986;232:1004–1007.
   PubMed Web of Science ®Google Scholar
• Gee KW, McCauley LD, Lan NC. A putative receptor for neurosteroids on the GABA receptor complex: the pharmacological properties and therapeutic potential of epalons. Crit Rev Neurobiol 1995;9:207–227.
   PubMedGoogle Scholar
• Valera S, Ballivet M, Bertrand D. Progesterone modulates a neuronal nicotinic acetylcholine receptor. Proc Natl Acad Sci USA 1992;89:9949–9953.
   PubMed Web of Science ®Google Scholar
• Hsueh AJW, Peck EJ, Clark JH. Control of uterine estrogen receptor levels by progesterone. Endocrinology 1976;98:438–444.
   PubMed Web of Science ®Google Scholar
• Herzog AG, Friedman MN, Freund S, Pascual-Leone A. Transcranial magnetic stimulation evidence of a potential role for progesterone in the modulation of premenstrual corticocortical inhibition in a woman with catamenial seizure exacerbation. Epilepsy Behav 2001;2:367–369.
   PubMed Web of Science ®Google Scholar
• Bonuccelli U, Melis GB, Paoletti AM, Fioretti P, Murri L, Muratorio A. Unbalanced progesterone and estradiol secretion in catamenial epilepsy. Epilepsy Res 1989;3:100–106.
   PubMed Web of Science ®Google Scholar
• Corpechot C, Young J, Calvel M,Wehrey C, Veltz JN, Touyer G, Mouren M, Prasad VV, Banner C, Sjovall J. Neurosteroids: 3-hydroxy-5-pregnan-20-one and its precursors in the brain, plasma and steroidogenic glands of male and female rats. Endocrinology 1993;133:1003–1009.
   PubMed Web of Science ®Google Scholar
• Harrison NL, Majewska MD, Harrington JW, Barker JL. Structure-activity relationships for steroid interactions with the -aminobutyric acid receptor complex. J Pharmacol Exp Ther 1987;241:346–353.
   PubMed Web of Science ®Google Scholar
• Lambert JJ, Belelli D, Peden DR, Vardy AW, Peters JA. Neurosteroid modulation of GABA-A receptors. Prog Neurobiol 2003;71:67–80.
   PubMed Web of Science ®Google Scholar
• Hosie AM, Wilkins ME, da Silva HM, Smart TG. Endogenous neurosteroids regulate GABA-A receptors through two discrete transmembrane sites. Nature 2006;444:486–489.
   PubMed Web of Science ®Google Scholar
• Rapkin AJ, Morgan M, Goldman L, Brann DW, Simone D, Mahesh VB. Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Obstet Gynecol 1997;190:709–714.
   Google Scholar
• Wang M, Seippel L, Purdy RH, Backstrom T. Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5-pregnane-3,20-dione and 3-hydroxy- 5-pregnan-20-one. J. Clin Endocrinol Metab 1996;81:1076–1082.
   PubMed Web of Science ®Google Scholar
• Genazzani AR, Petraglia F, Bernardi F, Casarosa E, Salvestroni C, Tonetti A. Circulating levels of allopregnanolone in humans: gender, age and endocrine influences. J Clin Endocrinol Metab 1998;83:2099–2103.
   PubMed Web of Science ®Google Scholar
• Cooper EJ, Johnston GA, Edwards FA. Effects of a naturally occurring neurosteroid on GABA-A IPSCs during development in rat hippocampal or cerebellar slices. J Physiol 1999;521:437–449.
   PubMed Web of Science ®Google Scholar
• Belelli D, Casula A, Ling A, Lambert JJ. The influence of subunit composition on the interaction of neurosteroids with GABA-A receptors. Neuropharmacology 2002;43:651–661.
   PubMed Web of Science ®Google Scholar
• Bixo M, Andersson A, Winblad B, Purdy RH, Backstrom T. Progesterone, 5-pregnane-3,20-dione and 3-hydroxy- 5-pregnane-20-one in specific regions of the human female brain in different endocrine states. Brain Res 1997;764:173–178.
   PubMed Web of Science ®Google Scholar
• Stoffel-Wagner B. Neurosteroid biosynthesis in the human brain and its clinical implications. Ann NY Acad Sci 2003;1007:64–78.
   PubMed Web of Science ®Google Scholar
• Herzog AG, Frye CA. Seizure exacerbation associated with inhibition of progesterone metabolism. Ann Neurol 2003;53:390–391.
   PubMed Web of Science ®Google Scholar
• Joels M, Karst H, Krugers HJ, Lucassen PJ. Chronic stress: implications for neuronal morphology, function and neurogenesis. Front Neuroendocrinol 2007;28:72–96.
   PubMed Web of Science ®Google Scholar
• Joels M. Steroid hormones and excitability in the mammalian brain. Front Neuroendocrinol 1997;18:2–48.
   PubMed Web of Science ®Google Scholar
• Reddy DS. Is there a physiological role for the neurosteroid THDOC in stress-sensitive conditions? Trends Pharmacol Sci 2003;24:103–106.
   PubMed Web of Science ®Google Scholar
• Reddy DS, Kulkarni SK. Proconvulsant effects of neurosteroids pregnenolone sulfate and dehydroepiandrosterone sulfate in mice. Eur J Pharmacol 1998;345:55–59.
   PubMed Web of Science ®Google Scholar
• Kokate TG, Juhng KN, Kirkby RD, Llamas J, Yamaguchi S, Rogawski MA. Convulsant actions of the neurosteroid pregnenolone sulfate in mice. Brain Res 1999;831:119–124.
   PubMed Web of Science ®Google Scholar
• Williamson J, Mtchedlishvili Z, Kapur J. Characterization of the convulsant action of pregnenolone sulfate. Neuropharmacology 2004;46:56–864.
   Web of Science ®Google Scholar
• Rush ME, Blake CA. Serum testosterone concentrations during the 4-day estrous cycle in normal and adrenalectomized rats. Proc Soc Exp Biol Med 1982;169:216–221.
   PubMed Web of Science ®Google Scholar
• Leranth C, Hajszan T, MacLusky NL. Androgens increase spine synapse density in the CA1 hippocampal subfield of ovariectomized female rats. J Neurosci 2004;24:495–499.
   PubMed Web of Science ®Google Scholar
• Doodipala SR. The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy. Epilepsy Research 2009;85:1–30.
   PubMed Web of Science ®Google Scholar
• Reddy DS. Testosterone modulation of seizure susceptibility is mediated by neurosteroids 3α-androstanediol and 17β-estradiol. Neuroscience 2004;129:195–207.
   PubMed Web of Science ®Google Scholar
• Reddy DS. Anticonvulsant activity of the testosteronederived neurosteroid 3-androstanediol. NeuroReport 2004;15:515–518.
   PubMed Web of Science ®Google Scholar
• Kaminski RM, Livingood MR, Rogawski MA. Allopregnanolone analogs that positively modulate GABA receptors protect against partial seizures induced by 6-Hz electrical stimulation in mice. Epilepsia 2004;45:864–867.
   PubMed Web of Science ®Google Scholar
• Kaminski RM, Marini H, Kim WJ, Rogawski MA. Anticonvulsant activity of androsterone and etiocholanolone. Epilepsia 2005;46:819–827.
   PubMed Web of Science ®Google Scholar
• Rogawski MA, Loscher W. The neurobiology of antiepileptic drugs. Nat Rev Neurosci 2004;5:553–564.
   PubMed Web of Science ®Google Scholar
• Isojarvi JI, Tauboll E, Herzog AG. Effect of antiepileptic drugs on reproductive endocrine function in individuals with epilepsy. CNS Drug 2005;19:207–223.
   PubMed Web of Science ®Google Scholar
• Murialdo G, Galimberti CA, Gianelli MV. Effects of valproate, phenobarbital, and carbamazepine on sex steroid setup in women with epilepsy. Clin Neuropharmacol 1998;21:52–58.
   PubMed Web of Science ®Google Scholar
• Morrell MJ, Guidice L, Flynn KL. Predictors of ovulatory failure in women with epilepsy. Ann Neurol 2002;52:704–711.
   PubMed Web of Science ®Google Scholar
• Herzog AG, Friedman MN. Menstrual cycle interval and ovulation in women with localization-related epilepsy. Neurology 2002;57:2133–2135.
   Web of Science ®Google Scholar
• Bauer J, Burr W, Elger CE. Seizure occurrence during ovulatory and anovulatory cycles in patients with temporal lobe epilepsy: a prospective study. Eur J Neurol 1998;5:83–88.
   PubMed Web of Science ®Google Scholar
• Mattson RH, Kamer JM, Cramer JA, Caldwell BV. Seizure frequency and the menstrual cycle: a clinical study. Epilepsia 1981;22:242.
   Web of Science ®Google Scholar
• Zimmerman AW, Holder DT, Reiter EO, Dekaban AS. Medroxyprogesterone acetate in the treatment of seizures associated with menstruation. J Pediatr 1973;83:959–963.
   PubMed Web of Science ®Google Scholar
• Mattson RH, Cramer JA, Caldwell BV, Siconolfi BC. Treatment of seizures with medroxyprogesterone acetate: preliminary report. Neurology 1984;34:1255–1258.
   PubMed Web of Science ®Google Scholar
• Foldvary-Schiaefer N, Harden C, Herzog A, Falcone T. Hormones and seizures. Cleve Clin J Med 2004;71:S11–S18.
   Google Scholar
• Herzog AG. Intermittent progesterone therapy of partial complex seizures in women with menstrual disorders. Neurology 1986;36:1607–1610.
   PubMed Web of Science ®Google Scholar
• Herzog AG. Progesterone therapy in women with complex partial and secondary generalized seizures. Neurology 1995;45:1600–1662.
   Web of Science ®Google Scholar
• Herzog AG. Progesterone therapy in women with epilepsy: a 3-year follow-up. Neurology 1999;52:1917–1918.
   PubMed Web of Science ®Google Scholar
• Herzog AG. Clomiphene therapy in epileptic women with menstrual disorders. Neurology 1988;38:432–434.
   PubMed Web of Science ®Google Scholar
• Bauer J, Wildt L, Flugel D, Stefan H. The effect of a synthetic GnRH analogue on catamenial epilepsy: a study in ten patients. J Neurol 1992;239:284–286.
   PubMed Web of Science ®Google Scholar
• Haider Y, Barnett DB. Catamenial epilepsy and goserelin. Lancet 1991;338:1530.
   PubMed Web of Science ®Google Scholar
• Reid B, Gangar KF. Catamenial epilepsy and goserelin. Lancet 1992;339:253–1253.
   PubMed Web of Science ®Google Scholar
• Livingston S. Comprehensive management of epilepsy in infancy, childhood and adolescence. Springfield, IL: Charles C Thomas; 1972.
   Google Scholar
• Ross IP. Acetazolamide therapy in epilepsy. Lancet 1958;2:1308–1309.
   PubMed Web of Science ®Google Scholar
• Ansell B, Clarke E. Epilepsy and menstruation. The role of water retention. Lancet 1956;2:1232–1235.
   Google Scholar
• Lombroso CT, Forxythe I. A long-term follow-up of acetazolamide (Diamox) in the treatment of epilepsy. Epilepsia 1960;1:493–500.
   PubMed Web of Science ®Google Scholar
• Millichap JG, Woodbury DM, Goodman BS. Mechanism of the anticonvulsant action of acetazolmide, a carbonic anhydrase inhibitor. J Pharmacol Exp Ther 1995;115:251–258.
   Google Scholar
• Reddy DS, Rogawski MA. Chronic treatment with the neuroactive steroid ganaxolone in the rat induces anticonvulsant tolerance to diazepam but not to itself. J Pharmacol Exp Ther 2000;295:1241–1248.
   PubMed Web of Science ®Google Scholar
• Ramaratham S. Successful treatment of a patient with refractory catamenial epilepsy with lamotrigine. SYCP Epilepsy 2003;10:18–20.
   Google Scholar
• Rogawski MA, Reddy DS. Neurosteroids: endogenous modulators of seizure susceptibility. In: Rho JM, Sankar R, Cavazos JE, editors. Epilepsy: scientific foundations of clinical practice. New York: Marcel Dekker; 2004. pp 319–355.
   Google Scholar
• Reddy DS, Rogawski MA. Enhanced anticonvulsant activity of neuroactive steroids in a rat model of catamenial epilepsy. Epilepsia 2001;42:303–310.
   Web of Science ®Google Scholar
• Reddy DS, Rogawski MA. Neurosteroid replacement therapy for catamenial epilepsy. Neurotherapeutics 2009;6:392–401.
   PubMed Web of Science ®Google Scholar
• Phillipps GH. Structure-activity relationships in steroidal anaesthetics. J Steroid Biochem 1975;6:607–613.
   PubMedGoogle Scholar
• Reddy DS, Woodward R. Ganaxolone: a prospective overview. Drugs future 2004;29:227–242.
   Web of Science ®Google Scholar